Wedbush Securities’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,600
| Closed | -$96K | – | 920 |
|
|
2018
Q1 | $96K | Hold |
10,600
| – | – | 0.01% | 756 |
|
|
2017
Q4 | $45K | Buy |
+10,600
| New | +$45K | 0.01% | 823 |
|
|
2017
Q2 | – | Sell |
-21,884
| Closed | -$56K | – | 892 |
|
|
2017
Q1 | $56K | Sell |
21,884
-3,400
| -13% | -$8.7K | 0.01% | 799 |
|
|
2016
Q4 | $64K | Sell |
25,284
-2,459
| -9% | -$6.22K | 0.01% | 769 |
|
|
2016
Q3 | $86K | Sell |
27,743
-2,595
| -9% | -$8.04K | 0.01% | 763 |
|
|
2016
Q2 | $97K | Hold |
30,338
| – | – | 0.02% | 698 |
|
|
2016
Q1 | $94K | Hold |
30,338
| – | – | 0.02% | 668 |
|
|
2015
Q4 | $122K | Sell |
30,338
-16,390
| -35% | -$65.9K | 0.02% | 633 |
|
|
2015
Q3 | $214K | Sell |
46,728
-3,382
| -7% | -$15.5K | 0.04% | 505 |
|
|
2015
Q2 | $260K | Buy |
50,110
+4,020
| +9% | +$20.9K | 0.05% | 474 |
|
|
2015
Q1 | $289K | Sell |
46,090
-4,950
| -10% | -$31K | 0.05% | 441 |
|
|
2014
Q4 | $321K | Sell |
51,040
-10,286
| -17% | -$64.7K | 0.05% | 384 |
|
|
2014
Q3 | $373K | Buy |
61,326
+20,790
| +51% | +$126K | 0.06% | 337 |
|
|
2014
Q2 | $267K | Buy |
40,536
+11,896
| +42% | +$78.4K | 0.04% | 436 |
|
|
2014
Q1 | $682K | Buy |
+28,640
| New | +$682K | 0.12% | 182 |
|